During the past decade, Katip Celebi University Ataturk Training and Research Hospital; Oncology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Izmir Ataturk Training and Research Hospital" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored and "Turkish Stroke Research and Clinical Trials Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" #1 collaborator was "Abbott Nutrition" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Klinar CRO" with 1 trials as a collaborator and "Turkish Neurological Society" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" are "Breast Cancer" (2 trials), "Urothelial Cancer" (2 trials), "Acute Ischemic Stroke" (1 trials), "Anxiety State" (1 trials) and "Costoclavicular and Infraclavicular Block for Patients Who Have Undergone Hand,Forearm and Arm Surgery" (1 trials). Many other conditions were trialed in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" in a lesser frequency.

Most popular intervention types in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" are "Drug" (9 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Giredestrant" (3 trials), "LHRH Agonist" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Katip Celebi University Ataturk Training and Research Hospital; Oncology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Katip Celebi University Ataturk Training and Research Hospital; Oncology". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Katip Celebi University Ataturk Training and Research Hospital; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Katip Celebi University Ataturk Training and Research Hospital; Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".